CLINICAL_TRIALS
trial_result
· 2026-03-31
Clinical Trial Update: 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis [Phase 3]
Summary
A 3-year Phase 3 open-label trial evaluating Lorecivivint for knee osteoarthritis was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosplice Therapeutics, Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: TERMINATED | Results posted: 2026-03-31